05/06/2024
6:04 AM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
6:06 AM | Omega Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2024
6:15 AM | Omega Therapeutics (Filer)
| Form DEFA14A | |
04/29/2024
6:00 AM | Omega Therapeutics (Filer)
| Form DEF 14A | |
04/16/2024
3:20 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
11:03 AM | Omega Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
3:17 PM | HarbourVest Partners L.P. (Filed by)
Omega Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
8:28 AM | FMR LLC (Filed by)
Omega Therapeutics (Subject)
| Form SC 13G/A | |
11/09/2023
6:03 AM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
6:03 AM | Omega Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/26/2023
4:29 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/22/2023
4:10 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2023
3:30 PM | Omega Therapeutics (Issuer)
Werner Michelle C (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/29/2023
3:32 PM | Omega Therapeutics (Issuer)
Werner Michelle C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
6:03 AM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/13/2023
3:00 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2023
3:21 PM | Omega Therapeutics (Issuer)
SCHADE CHRISTIAN S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/12/2023
3:01 PM | Omega Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/12/2023
3:15 PM | Omega Therapeutics (Issuer)
SCHADE CHRISTIAN S (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
